Law channel feed

House com­mit­tee chair re­quests in­fo from FDA on fund­ing for tri­als in­volv­ing 'vi­ral ma­nip­u­la­tion'

3 years ago
FDA+

Es­pe­ri­on sues Dai­ichi Sankyo, de­mand­ing pay­ment of $300M mile­stone for car­dio drug

3 years ago
Pharma

Heat­ed oral ar­gu­ments at SCO­TUS hint at Sanofi-Re­gen­eron edge over Am­gen in patent spat

3 years ago

Judge al­lows ex­pert tes­ti­mo­ny in GSK tri­al al­leg­ing Zan­tac link to can­cer

3 years ago
Pharma

Sen­ate com­mit­tee ad­vances PBM bill as bi­par­ti­san re­forms gain trac­tion

3 years ago
Pharma

Pa­tients ap­peal NI­H's re­jec­tion to use 'march-in' rights on Astel­las' prostate can­cer drug Xtan­di

3 years ago

Fed­er­al judge de­nies Am­gen's mo­tion to dis­miss Re­gen­eron an­titrust case

3 years ago
Pharma

NIH re­jects an­oth­er at­tempt to 'march-in' on Astel­las' prostate can­cer drug over ex­ces­sive price

3 years ago
Pharma

FTC says patent bat­tle over Parkin­son's drug could have 'sig­nif­i­cant im­pli­ca­tion­s' for pa­tients

3 years ago
Pharma

One fi­nal push: EU phar­ma in­dus­try group de­mands com­pe­ti­tion check on in­com­ing leg­isla­tive over­haul

3 years ago
Pharma

A sign of what's com­ing? Pres­i­den­tial hope­ful De­San­tis tar­gets PBMs and phar­ma trans­paren­cy

3 years ago
People

Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs

3 years ago
Pharma

J&J fi­nal­izes $25M set­tle­ment, lay­ing Rem­i­cade an­titrust al­le­ga­tions to rest

3 years ago
Pharma

Mod­er­na's 'sur­prise' IP court or­der could set up a big set­tle­ment for Roivant, Ar­bu­tus — an­a­lysts

3 years ago

CMS ex­plains how it will ne­go­ti­ate the most ex­pen­sive drug prices with bio­phar­ma be­gin­ning in 2026

3 years ago
Pharma

Up­dat­ed: Am­gen sued in fed­er­al court for al­leged­ly hid­ing $10.7B IRS bill from in­vestors

3 years ago
Pharma

Five Pfiz­er drugs among first 27 now sub­ject to Medicare in­fla­tion re­bates, HHS says

3 years ago
Pharma

Sun Phar­ma, Taro Phar­ma­ceu­ti­cal reach $75M set­tle­ment agree­ment in al­leged price fix­ing scheme

3 years ago
R&D

Pfiz­er CEO points to IRA as a fac­tor that made Seagen an at­trac­tive tar­get

3 years ago
Pharma

Biden bud­get wants to more than dou­ble num­ber of ne­go­ti­at­ed drugs un­der Medicare, and elim­i­nate he­pati­tis C

3 years ago
FDA+

On­copep­tides ex­ec is ar­rest­ed in Swe­den for al­leged­ly pass­ing in­sid­er in­for­ma­tion

3 years ago
People

Bris­tol My­ers ax­es Ger­man launch of new can­cer drug, cit­ing pric­ing hur­dles

3 years ago
Pharma

Biden pro­pos­es ex­tend­ing Medicare price ne­go­ti­a­tions to more drugs

3 years ago
FDA+

UK gov­ern­ment plans to hike rev­enue claw­back rates be­gin­ning in April

3 years ago
Financing
Pharma
First page Previous page 22232425262728 Next page Last page
A service from the Financial Times